Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
Angiopoietin-like 4 (ANGPTL4) is an emerging therapeutic and diagnostic target for DR. Cell-based, animal, and clinical studies have collectively identified ANGPTL4 as a specific biomarker for DR. Its concentration level in aqueous humor and serum has a significant dose-dependent relationship with disease severity. Accurate monitoring of ANGPTL4 provides an effective tool for DR screening, diagnosis, treatment, and management.Tremendous effort has been devoted to developing cost-efficient and convenient diagnostic techniques for detection of disease-specific protein biomarkers.
Aptamer has low immunogenicity and toxicity; they can be prepared by chemical synthesis and are easy to modify and label; they are less affected by environmental factors, such as pH and temperature; they have structural stability; and they have a wide range of recognition targets and strong
specificity.